EDGAR Filing Documents for 0000950133-05-004188

Form SC 13G - Statement of Beneficial Ownership by Certain Investors:

SEC Accession No. 0000950133-05-004188

Filing Date

2005-09-19

Accepted

2005-09-19 16:47:54

Documents

Group Members

BIOTECH TARGET, N.V.

Document Format Files

Seq	Description	Document	Type	Size
1	SCHEDULE 13G	w12888sc13g.htm	SC 13G	71563
	Complete submission text file	0000950133-05-004188.txt		73454

Mailing Address VODERGASSE 3 SWITZERLAND SCHAFFHAUSEN V8 CH-8300

Business Address VODERGASSE 3 SWITZERLAND SCHAFFHAUSEN V8 CH-8300 411724 59 59

State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13G
SIC: 0000

Mailing Address 3115 MERRYFIELD ROW SAN DIEGO CA 92121

Business Address 3115 MERRYFIELD ROW SAN DIEGO CA 92121 8585303600

ANADYS PHARMACEUTICALS INC (Subject) CIK: 0001128495 (see all company filings)

IRS No.: 223193172
Type: SC 13G | Act: 34 | File No.: 005-79854 | Film No.: 051091704
SIC: 2834 Pharmaceutical Preparations